dipyridamole has been researched along with Kawasaki Disease in 42 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole stress integrated backscatter (IBS) was used for evaluation of myocardial ischemia or damage in 31 children with coronary artery lesions caused by Kawasaki disease, in comparison with thallium-201 myocardial imaging." | 9.09 | Dipyridamole stress ultrasonic myocardial tissue characterization in patients with Kawasaki disease. ( Hamamichi, Y; Hashimoto, I; Ichida, F; Miyawaki, T; Sahn, DJ; Seto, H; Tsubata, S; Yu, X, 2001) |
| "To evaluate diagnostic accuracy of dipyridamole stress technetium-99 m tetrofosmin, single-photon emission computed tomography as a possible alternative to invasive coronary angiography for detection and follow-up of myocardial ischaemia in patients with Kawasaki disease, and pre- and post-coronary bypass grafting." | 7.81 | Assessment of coronary ischaemia by myocardial perfusion dipyridamole stress technetium-99 m tetrofosmin, single-photon emission computed tomography, and coronary angiography in children with Kawasaki disease: pre- and post-coronary bypass grafting. ( Al Said, YM; Mostafa, MS; Sayed, AO, 2015) |
| "Dobutamine (DOB) stress radionuclide ventriculography (RVG) is proposed for evaluating left ventricular performance in patients with Kawasaki disease (KD)." | 7.71 | Dobutamine stress radionuclide ventriculography reveals silent myocardial dysfunction in Kawasaki disease. ( Hamamichi, Y; Hashimoto, I; Hirono, K; Ichida, F; Miyawaki, T; Origasa, H; Rui, C; Seto, H; Simizu, M; Tsubata, S; Uese, K; Watanabe, S; Yu, X, 2002) |
| "Dipyridamole-thallium SPECT is safely performed and is useful and important for risk stratification in the long-term follow-up of patients with Kawasaki disease." | 7.70 | Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease. ( Hamamoto, K; Ikezoe, J; Matsumoto, S; Miyagawa, M; Mochizuki, T; Murase, K; Niino, M; Sekiya, M; Tanada, S, 1998) |
| "The long-term outcome of coronary aneurysm after Kawasaki disease was investigated using dipyridamole-loading angiography in 33 children with coronary aneurysms after Kawasaki disease." | 7.70 | Morphologic and functional assessment of coronary aneurysm after Kawasaki disease by repeated dipyridamole-loading coronary angiography. ( Shinohara, M; Sone, K; Tomomasa, T, 1998) |
| "Positron emission tomography and H2(15)O were used to characterize regional myocardial blood flow and distribution at rest and in response to dipyridamole in children with Kawasaki disease but without angiographic evidence of coronary stenosis." | 7.69 | Assessment of effects of intravenous dipyridamole on regional myocardial perfusion in children with Kawasaki disease without angiographic evidence of coronary stenosis using positron emission tomography and H2(15)O. ( Hamaoka, K; Oda, Y; Ohmochi, Y; Onouchi, Z, 1995) |
| "Thirty-eight patients with coronary arterial involvement of Kawasaki disease and 18 control subjects received cardiac ultrafast CT with intravenous long-bolus iodinated contrast injection; dipyridamole was loaded in 40 examinations." | 7.69 | Significance of dipyridamole loading in ultrafast x-ray computed tomography for detection of myocardial ischemia. A study in patients with Kawasaki disease. ( Hamada, S; Kamiya, T; Naito, H; Takamiya, M; Tamura, S; Yoshibayashi, M, 1995) |
| "Dipyridamole-loading cineventriculography was performed to evaluate left ventricular (LV) function in 76 patients with Kawasaki disease." | 7.68 | Assessment of left ventricular function in Kawasaki disease by dipyridamole-loading cineventriculography. ( Kosuda, T; Sone, K, 1992) |
| "In order to compare the clinical effects of exercise-loading and intravenous dipyridamole-loading tests in evaluating ischemic coronary lesion and coronary reserve, we evaluated changes in ECG, 201-Tl scintigraphy, coronary flow and myocardial metabolism in 10 patients with Kawasaki disease (age range: 7-16 years)." | 7.68 | [Exercise and dipyridamole-loading in evaluation of ischemic coronary lesion and coronary reserve in children with Kawasaki disease]. ( Hamaoka, K; Ohmochi, Y; Onouchi, Z; Sakata, K, 1991) |
| "Thallium-201 myocardial imaging was performed at rest in 131 children with coronary arterial lesions due to Kawasaki disease." | 7.67 | [Diagnosis of myocardial ischemia in Kawasaki disease: thallium-201 myocardial imagings at rest, with exercise and with dipyridamole administration]. ( Kamiya, T; Kozuka, T; Mitomori, T; Nishimura, T; Ono, Y; Sugiyama, H; Suzuki, A, 1984) |
| "The authors evaluated the distensibility of the coronary arterial wall by pharmacoangiography with intravenous administration of dipyridamole in 38 patients with Kawasaki disease." | 7.67 | Coronary angiography of Kawasaki disease with the coronary vasodilator dipyridamole: assessment of distensibility of affected coronary arterial wall. ( Hirano, T; Ito, T; Matsumura, K; Okuda, Y; Takeda, K; Yamaguchi, N, 1988) |
| "Kawasaki disease (mucocutaneous lymph node syndrome) is a disease of unknown aetiology that affects infants and children, with most patients having myocardial involvement." | 5.30 | Kawasaki disease evaluated by two-dimensional echocardiogram and dipyridamole 201Tl-chloride myocardial SPET. ( Chang, JS; Kao, CH; Lee, JK; Shih, WJ; Tsai, CH, 1997) |
| "Thirty-eight patients with Kawasaki disease and 11 age-matched controls participated in the study." | 5.30 | Noninvasive evaluation of myocardial ischemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing. ( Akagi, T; Fukuda, T; Inoue, O; Ishibashi, M; Kato, H; Sugimura, T, 1998) |
| "The detection of myocardial ischemia is essential for evaluation of patients with Kawasaki disease, especially who have had coronary artery lesions." | 5.28 | Myocardial ischemia in Kawasaki disease; evaluation by dipyridamole stress thallium-201 (Tl-201) myocardial imaging and exercise stress test. ( Fukuda, T, 1992) |
| "Dipyridamole stress integrated backscatter (IBS) was used for evaluation of myocardial ischemia or damage in 31 children with coronary artery lesions caused by Kawasaki disease, in comparison with thallium-201 myocardial imaging." | 5.09 | Dipyridamole stress ultrasonic myocardial tissue characterization in patients with Kawasaki disease. ( Hamamichi, Y; Hashimoto, I; Ichida, F; Miyawaki, T; Sahn, DJ; Seto, H; Tsubata, S; Yu, X, 2001) |
| "To evaluate diagnostic accuracy of dipyridamole stress technetium-99 m tetrofosmin, single-photon emission computed tomography as a possible alternative to invasive coronary angiography for detection and follow-up of myocardial ischaemia in patients with Kawasaki disease, and pre- and post-coronary bypass grafting." | 3.81 | Assessment of coronary ischaemia by myocardial perfusion dipyridamole stress technetium-99 m tetrofosmin, single-photon emission computed tomography, and coronary angiography in children with Kawasaki disease: pre- and post-coronary bypass grafting. ( Al Said, YM; Mostafa, MS; Sayed, AO, 2015) |
| "Dobutamine (DOB) stress radionuclide ventriculography (RVG) is proposed for evaluating left ventricular performance in patients with Kawasaki disease (KD)." | 3.71 | Dobutamine stress radionuclide ventriculography reveals silent myocardial dysfunction in Kawasaki disease. ( Hamamichi, Y; Hashimoto, I; Hirono, K; Ichida, F; Miyawaki, T; Origasa, H; Rui, C; Seto, H; Simizu, M; Tsubata, S; Uese, K; Watanabe, S; Yu, X, 2002) |
| "Dipyridamole-thallium SPECT is safely performed and is useful and important for risk stratification in the long-term follow-up of patients with Kawasaki disease." | 3.70 | Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease. ( Hamamoto, K; Ikezoe, J; Matsumoto, S; Miyagawa, M; Mochizuki, T; Murase, K; Niino, M; Sekiya, M; Tanada, S, 1998) |
| "The long-term outcome of coronary aneurysm after Kawasaki disease was investigated using dipyridamole-loading angiography in 33 children with coronary aneurysms after Kawasaki disease." | 3.70 | Morphologic and functional assessment of coronary aneurysm after Kawasaki disease by repeated dipyridamole-loading coronary angiography. ( Shinohara, M; Sone, K; Tomomasa, T, 1998) |
| "Positron emission tomography and H2(15)O were used to characterize regional myocardial blood flow and distribution at rest and in response to dipyridamole in children with Kawasaki disease but without angiographic evidence of coronary stenosis." | 3.69 | Assessment of effects of intravenous dipyridamole on regional myocardial perfusion in children with Kawasaki disease without angiographic evidence of coronary stenosis using positron emission tomography and H2(15)O. ( Hamaoka, K; Oda, Y; Ohmochi, Y; Onouchi, Z, 1995) |
| "Thirty-eight patients with coronary arterial involvement of Kawasaki disease and 18 control subjects received cardiac ultrafast CT with intravenous long-bolus iodinated contrast injection; dipyridamole was loaded in 40 examinations." | 3.69 | Significance of dipyridamole loading in ultrafast x-ray computed tomography for detection of myocardial ischemia. A study in patients with Kawasaki disease. ( Hamada, S; Kamiya, T; Naito, H; Takamiya, M; Tamura, S; Yoshibayashi, M, 1995) |
| "The diagnostic significance of dipyridamole-provoked chest pain was studied in 17 children with severe coronary arterial stenotic lesions (CAL) complicated with Kawasaki disease." | 3.68 | Dipyridamole-provoked chest pain implies severe coronary artery disease in children. ( Chiba, S; Ikeda, K; Kubota, M; Nagata, N; Tomita, H; Tsuda, T, 1993) |
| "To assess the usefulness of radionuclide tests in detecting coronary occlusive lesions in children with Kawasaki disease, we compared the results of stress thallium-201 myocardial single photon emission computed tomography with dipyridamole infusion and coronary angiography in 34 patients (19 males and 15 females)." | 3.68 | Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram. ( Fukazawa, M; Fukushige, J; Hijii, T; Ichiya, Y; Igarashi, H; Kuwabara, Y; Narabayashi, H; Otsuka, M; Takeuchi, T; Ueda, K, 1993) |
| "The effects of isosorbide dinitrate (ISDN) on the coronary and systemic circulation were evaluated in comparison with the effects of dipyridamole (DP) in 8 children with histories of Kawasaki disease and angiographically normal coronary arteries." | 3.68 | [Effects of isosorbide dinitrate on coronary and systemic circulation in children: comparison with dipyridamole]. ( Hamaoka, K; Kamiya, Y; Ohmochi, Y; Onouchi, Z; Sakata, K, 1992) |
| "Dipyridamole-loading cineventriculography was performed to evaluate left ventricular (LV) function in 76 patients with Kawasaki disease." | 3.68 | Assessment of left ventricular function in Kawasaki disease by dipyridamole-loading cineventriculography. ( Kosuda, T; Sone, K, 1992) |
| "In order to compare the clinical effects of exercise-loading and intravenous dipyridamole-loading tests in evaluating ischemic coronary lesion and coronary reserve, we evaluated changes in ECG, 201-Tl scintigraphy, coronary flow and myocardial metabolism in 10 patients with Kawasaki disease (age range: 7-16 years)." | 3.68 | [Exercise and dipyridamole-loading in evaluation of ischemic coronary lesion and coronary reserve in children with Kawasaki disease]. ( Hamaoka, K; Ohmochi, Y; Onouchi, Z; Sakata, K, 1991) |
| "Thallium-201 myocardial imaging was performed at rest in 131 children with coronary arterial lesions due to Kawasaki disease." | 3.67 | [Diagnosis of myocardial ischemia in Kawasaki disease: thallium-201 myocardial imagings at rest, with exercise and with dipyridamole administration]. ( Kamiya, T; Kozuka, T; Mitomori, T; Nishimura, T; Ono, Y; Sugiyama, H; Suzuki, A, 1984) |
| "This study determined the feasibility and accuracy of quantitative 201Tl myocardial single-photon emission computed tomography (SPECT) after dipyridamole infusion to detect coronary obstructive lesions in children with Kawasaki disease." | 3.67 | Detection of coronary artery stenosis in children with Kawasaki disease. Usefulness of pharmacologic stress 201Tl myocardial tomography. ( Hiroe, M; Kondo, C; Nakanishi, T; Takao, A, 1989) |
| "The authors evaluated the distensibility of the coronary arterial wall by pharmacoangiography with intravenous administration of dipyridamole in 38 patients with Kawasaki disease." | 3.67 | Coronary angiography of Kawasaki disease with the coronary vasodilator dipyridamole: assessment of distensibility of affected coronary arterial wall. ( Hirano, T; Ito, T; Matsumura, K; Okuda, Y; Takeda, K; Yamaguchi, N, 1988) |
| "Indeed, Kawasaki disease is induced by overreaction of innate cells following exposition to various viruses, including herpes viruses which trigger STING." | 2.66 | Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway? ( Berthelot, JM; Drouet, L; Lioté, F, 2020) |
| "We report a 1-month-old infant with Kawasaki disease and peripheral gangrene." | 1.33 | Infantile Kawasaki disease and peripheral gangrene. ( Durall, AL; Mullett, CJ; Phillips, JR; Weisse, ME, 2006) |
| "Kawasaki disease is an acute vasculitis of unknown cause that affects children under 5 years of age and in 20-25% of cases can cause coronary artery anomalies." | 1.31 | [Cardiac involvement in Kawasaki disease. Our experience]. ( Barone, P; Betta, P; Distefano, G; Falsaperla, R; Marletta, M; Mattia, C; Sciacca, P; Tornambene, G, 2001) |
| "Thirty-eight patients with Kawasaki disease and 11 age-matched controls participated in the study." | 1.30 | Noninvasive evaluation of myocardial ischemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing. ( Akagi, T; Fukuda, T; Inoue, O; Ishibashi, M; Kato, H; Sugimura, T, 1998) |
| "Kawasaki disease (mucocutaneous lymph node syndrome) is a disease of unknown aetiology that affects infants and children, with most patients having myocardial involvement." | 1.30 | Kawasaki disease evaluated by two-dimensional echocardiogram and dipyridamole 201Tl-chloride myocardial SPET. ( Chang, JS; Kao, CH; Lee, JK; Shih, WJ; Tsai, CH, 1997) |
| "Aspirin was used in most patients often in conjunction with dipyridamole and from 1986 intravenous immunoglobulin was given routinely to those patients seen early in the illness." | 1.28 | Clinical aspects of 100 patients with Kawasaki disease. ( Dillon, MJ; Levin, M; Suzuki, A; Tizard, EJ, 1991) |
| " DIP was infused at a dosage of 0." | 1.28 | Dipyridamole-induced ischemia in a child with jeopardized collaterals after Kawasaki syndrome. ( Matsuo, N; Matsuura, H; Saji, T; Umezawa, T; Yabe, Y; Yamamoto, S, 1990) |
| "The detection of myocardial ischemia is essential for evaluation of patients with Kawasaki disease, especially who have had coronary artery lesions." | 1.28 | Myocardial ischemia in Kawasaki disease; evaluation by dipyridamole stress thallium-201 (Tl-201) myocardial imaging and exercise stress test. ( Fukuda, T, 1992) |
| "The diagnosis of Kawasaki disease and echocardiographic evaluation of the coronary arteries should be considered in young infants with prolonged fever of unknown origin." | 1.27 | Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. ( Burns, JC; Glodé, MP; Leung, DY; Newburger, JW; Toews, WH; Wiggins, JW; Wilson, H, 1986) |
| " Optimum drug or combination of drugs and dosage are still controversial." | 1.26 | [Inhibition of platelet function in pediatric medicine (author's transl)]. ( Schmidt, B, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (19.05) | 18.7374 |
| 1990's | 20 (47.62) | 18.2507 |
| 2000's | 8 (19.05) | 29.6817 |
| 2010's | 5 (11.90) | 24.3611 |
| 2020's | 1 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Berthelot, JM | 1 |
| Drouet, L | 1 |
| Lioté, F | 1 |
| Zhang, Y | 2 |
| Wan, H | 1 |
| Du, M | 1 |
| Deng, H | 1 |
| Fu, J | 1 |
| Wang, X | 1 |
| Liu, R | 1 |
| De Rosa, G | 1 |
| Andreozzi, L | 1 |
| Piastra, M | 1 |
| Castelli, B | 1 |
| Rigante, D | 1 |
| Mostafa, MS | 1 |
| Sayed, AO | 1 |
| Al Said, YM | 1 |
| Muneuchi, J | 1 |
| Ishimura, M | 1 |
| Takada, H | 1 |
| Hoshina, T | 1 |
| Utsunomiya, R | 1 |
| Ikeda, K | 2 |
| Yamaguchi, K | 1 |
| Ohga, S | 1 |
| Kusuhara, K | 1 |
| Hara, T | 1 |
| Hasegawa, S | 1 |
| Sato, S | 1 |
| Numano, F | 1 |
| Park, J | 1 |
| Hoshina, S | 1 |
| Endoh, H | 1 |
| Suzuki, H | 1 |
| Uchiyama, M | 1 |
| Lee, PC | 1 |
| Shiau, YC | 2 |
| Fu, YC | 3 |
| Kao, A | 2 |
| Lin, CC | 1 |
| Lee, CC | 1 |
| Tsai, SC | 2 |
| Hwang, B | 2 |
| Chi, CS | 2 |
| Liu, FY | 1 |
| Ishikawa, Y | 1 |
| Fujiwara, M | 1 |
| Ono, Y | 3 |
| Tsuda, E | 1 |
| Matsubara, T | 1 |
| Furukawa, S | 1 |
| Echigo, S | 1 |
| Durall, AL | 1 |
| Phillips, JR | 1 |
| Weisse, ME | 1 |
| Mullett, CJ | 1 |
| Hayashi, H | 1 |
| Kisamori, K | 1 |
| Kaneko, M | 1 |
| Masumura, Y | 1 |
| Kamikawa, T | 1 |
| Kobayashi, A | 1 |
| Suzuki, Y | 1 |
| Yamazaki, N | 1 |
| Yamaguchi, T | 1 |
| Harada, Y | 1 |
| Cheatham, JP | 1 |
| Kugler, JD | 1 |
| Pinsky, WW | 1 |
| Hofschire, PJ | 1 |
| Mitomori, T | 1 |
| Sugiyama, H | 1 |
| Suzuki, A | 3 |
| Kamiya, T | 3 |
| Nishimura, T | 2 |
| Kozuka, T | 1 |
| Schmidt, B | 1 |
| Ohmochi, Y | 3 |
| Onouchi, Z | 3 |
| Oda, Y | 1 |
| Hamaoka, K | 3 |
| Naito, H | 1 |
| Hamada, S | 1 |
| Takamiya, M | 2 |
| Yoshibayashi, M | 1 |
| Tamura, S | 1 |
| Tomita, H | 1 |
| Nagata, N | 1 |
| Chiba, S | 1 |
| Kubota, M | 1 |
| Tsuda, T | 1 |
| Kondo, C | 2 |
| Nakanishi, T | 2 |
| Sonobe, T | 1 |
| Tatara, K | 1 |
| Momma, K | 1 |
| Kusakabe, K | 1 |
| Fukazawa, M | 1 |
| Fukushige, J | 1 |
| Takeuchi, T | 1 |
| Narabayashi, H | 1 |
| Igarashi, H | 1 |
| Hijii, T | 1 |
| Ueda, K | 1 |
| Kuwabara, Y | 1 |
| Otsuka, M | 1 |
| Ichiya, Y | 1 |
| Tsai, CH | 1 |
| Lee, JK | 1 |
| Kao, CH | 1 |
| Chang, JS | 1 |
| Shih, WJ | 1 |
| Rossomando, V | 1 |
| Baracchini, A | 1 |
| Chiaravalloti, G | 1 |
| Assanta, N | 1 |
| Buti, G | 1 |
| Matteucci, L | 1 |
| Ceccarelli, M | 1 |
| Fukuda, T | 2 |
| Akagi, T | 1 |
| Ishibashi, M | 1 |
| Inoue, O | 1 |
| Sugimura, T | 1 |
| Kato, H | 1 |
| Shinohara, M | 2 |
| Sone, K | 3 |
| Tomomasa, T | 2 |
| Miyagawa, M | 1 |
| Mochizuki, T | 1 |
| Murase, K | 1 |
| Tanada, S | 1 |
| Ikezoe, J | 1 |
| Sekiya, M | 1 |
| Hamamoto, K | 1 |
| Matsumoto, S | 1 |
| Niino, M | 1 |
| Kaneko, K | 1 |
| Obinata, K | 1 |
| Katsumata, K | 1 |
| Tawa, T | 1 |
| Hosaka, A | 1 |
| Yamashiro, Y | 1 |
| Morikawa, A | 1 |
| Sciacca, P | 1 |
| Falsaperla, R | 1 |
| Barone, P | 1 |
| Tornambene, G | 1 |
| Mattia, C | 1 |
| Marletta, M | 1 |
| Betta, P | 1 |
| Distefano, G | 1 |
| Yu, X | 2 |
| Hashimoto, I | 2 |
| Ichida, F | 2 |
| Hamamichi, Y | 2 |
| Tsubata, S | 2 |
| Miyawaki, T | 2 |
| Seto, H | 2 |
| Sahn, DJ | 1 |
| Hirono, K | 1 |
| Watanabe, S | 1 |
| Rui, C | 1 |
| Uese, K | 1 |
| Simizu, M | 1 |
| Origasa, H | 1 |
| Kamiya, Y | 1 |
| Sakata, K | 2 |
| Kosuda, T | 1 |
| Houly, SR | 1 |
| Houly, RS | 1 |
| Oliveira, CC | 1 |
| de Albuquerque, PF | 1 |
| Coutinho, MA | 1 |
| Santos, RJ | 1 |
| Lira, N | 1 |
| Lira Neto, FS | 1 |
| Kohata, T | 1 |
| Iwatani, H | 1 |
| Okuno, M | 1 |
| Tizard, EJ | 1 |
| Levin, M | 1 |
| Dillon, MJ | 1 |
| Yamamoto, S | 1 |
| Matsuura, H | 1 |
| Umezawa, T | 1 |
| Saji, T | 1 |
| Matsuo, N | 1 |
| Yabe, Y | 1 |
| Hiroe, M | 1 |
| Takao, A | 1 |
| Nienaber, CA | 1 |
| Spielmann, RP | 1 |
| Hausdorf, G | 1 |
| Matsumura, K | 1 |
| Okuda, Y | 1 |
| Ito, T | 1 |
| Hirano, T | 1 |
| Takeda, K | 1 |
| Yamaguchi, N | 1 |
| Burns, JC | 1 |
| Wiggins, JW | 1 |
| Toews, WH | 1 |
| Newburger, JW | 1 |
| Leung, DY | 1 |
| Wilson, H | 1 |
| Glodé, MP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000520] | Phase 2 | 0 participants | Interventional | 1985-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for dipyridamole and Kawasaki Disease
| Article | Year |
|---|---|
Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?
Topics: Angiotensin II; Animals; Aspirin; Blood Coagulation Disorders; Coronavirus Infections; COVID-19; Dip | 2020 |
Kawasaki disease in Nebraska: a review of the literature.
Topics: Adrenal Cortex Hormones; Aneurysm; Anticoagulants; Aspirin; Blood Sedimentation; Child; Child, Presc | 1983 |
1 trial available for dipyridamole and Kawasaki Disease
| Article | Year |
|---|---|
Dipyridamole stress ultrasonic myocardial tissue characterization in patients with Kawasaki disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Dipyridamole; Echocardiography; Female; Humans; Male; Mu | 2001 |
39 other studies available for dipyridamole and Kawasaki Disease
| Article | Year |
|---|---|
Capillary leak syndrome and aseptic meningitis in a patient with Kawasaki disease: A case report.
Topics: Aspirin; Capillary Leak Syndrome; Dipyridamole; Diuretics; Furosemide; Glucocorticoids; Humans; Immu | 2018 |
Acute myocarditis as a revealing clue of complete Kawasaki disease.
Topics: Acute Disease; Aspirin; Child, Preschool; Dipyridamole; Drug Substitution; Female; Humans; Immunoglo | 2018 |
Assessment of coronary ischaemia by myocardial perfusion dipyridamole stress technetium-99 m tetrofosmin, single-photon emission computed tomography, and coronary angiography in children with Kawasaki disease: pre- and post-coronary bypass grafting.
Topics: Child; Child, Preschool; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Female; Humans; | 2015 |
Incomplete Kawasaki disease in a patient with chronic granulomatous disease.
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; Coronary Angiography; Dipyridamole; Follow-Up Studies; | 2010 |
Characteristic alteration in the second derivative of photoplethysmogram in children.
Topics: Adolescent; Blood Pressure; Child; Child, Preschool; Dipyridamole; Female; Heart Rate; Humans; Infan | 2011 |
Discordance between dipyridamole technetium-99m-sestamibi myocardial perfusion single photon emission computed tomography and two-dimensional echocardiography in Kawasaki disease--a preliminary report.
Topics: Adolescent; Child; Child, Preschool; Coronary Aneurysm; Coronary Disease; Dipyridamole; Echocardiogr | 2002 |
Discordance between dipyridamole stress technetium-99m tetrofosmin single photon emission computed tomography and coronary angiography in patients with Kawasaki disease.
Topics: Adolescent; Child; Child, Preschool; Coronary Angiography; Coronary Disease; Dipyridamole; Female; H | 2002 |
Poor agreement between dipyridamole-stress technetium-99m-tetrofosmin myocardial perfusion single photon emission computed tomography and two-dimensional echocardiography in Kawasaki disease.
Topics: Adolescent; Child; Child, Preschool; Coronary Circulation; Dipyridamole; Echocardiography; Female; H | 2003 |
Exercise- or dipyridamole-loaded QGS is useful to evaluate myocardial ischemia and viability in the patients with a history of Kawasaki disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Coronary Stenosis; Dipyridamole; Exercise Test; Female; | 2005 |
Infantile Kawasaki disease and peripheral gangrene.
Topics: Abciximab; Amputation, Surgical; Anti-Bacterial Agents; Antibodies, Monoclonal; Anticoagulants; Anti | 2006 |
Unstable angina in a patient with mucocutaneous lymph node syndrome.
Topics: Aneurysm; Angina Pectoris; Angina, Unstable; Aspirin; Child; Coronary Angiography; Coronary Artery B | 1984 |
[Diagnosis of myocardial ischemia in Kawasaki disease: thallium-201 myocardial imagings at rest, with exercise and with dipyridamole administration].
Topics: Adolescent; Angiography; Child, Preschool; Coronary Disease; Dipyridamole; Exercise Test; Female; Hu | 1984 |
[Inhibition of platelet function in pediatric medicine (author's transl)].
Topics: Age Factors; Aspirin; Child; Dipyridamole; Glomerulonephritis; Graft Rejection; Heart Defects, Conge | 1982 |
Assessment of effects of intravenous dipyridamole on regional myocardial perfusion in children with Kawasaki disease without angiographic evidence of coronary stenosis using positron emission tomography and H2(15)O.
Topics: Adolescent; Adult; Coronary Aneurysm; Coronary Angiography; Coronary Circulation; Dipyridamole; Elec | 1995 |
Significance of dipyridamole loading in ultrafast x-ray computed tomography for detection of myocardial ischemia. A study in patients with Kawasaki disease.
Topics: Adolescent; Adult; Blood Pressure; Child; Child, Preschool; Contrast Media; Dipyridamole; Female; He | 1995 |
Dipyridamole-provoked chest pain implies severe coronary artery disease in children.
Topics: Adolescent; Angina Pectoris; Child; Child, Preschool; Coronary Angiography; Coronary Disease; Dipyri | 1993 |
Scintigraphic monitoring of coronary artery occlusion due to Kawasaki disease.
Topics: Coronary Aneurysm; Coronary Angiography; Coronary Disease; Coronary Vessels; Dipyridamole; Humans; M | 1993 |
Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram.
Topics: Adolescent; Child; Child, Preschool; Coronary Angiography; Coronary Circulation; Dipyridamole; Exerc | 1993 |
Kawasaki disease evaluated by two-dimensional echocardiogram and dipyridamole 201Tl-chloride myocardial SPET.
Topics: Child; Child, Preschool; Diagnostic Errors; Dipyridamole; Echocardiography; Female; Heart; Humans; I | 1997 |
[Atypical and incomplete Kawasaki disease].
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Immunoglobulins, Intravenous; Infant; Male | 1997 |
Noninvasive evaluation of myocardial ischemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing.
Topics: Child; Child, Preschool; Dipyridamole; Exercise Test; Female; Humans; Infant; Male; Mucocutaneous Ly | 1998 |
Morphologic and functional assessment of coronary aneurysm after Kawasaki disease by repeated dipyridamole-loading coronary angiography.
Topics: Adolescent; Cardiac Catheterization; Child; Child, Preschool; Coronary Aneurysm; Coronary Angiograph | 1998 |
Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease.
Topics: Age of Onset; Angina, Unstable; Blood Pressure; Child; Coronary Angiography; Coronary Artery Bypass; | 1998 |
Kawasaki disease in a father and daughter.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Child, Preschool; Dipyridamole; | 1999 |
Corticosteroids in the treatment of the acute phase of Kawasaki disease.
Topics: Acute Disease; Aspirin; Child, Preschool; Coronary Aneurysm; Dipyridamole; Drug Therapy, Combination | 1999 |
[Cardiac involvement in Kawasaki disease. Our experience].
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Coronary Aneurysm; | 2001 |
Dobutamine stress radionuclide ventriculography reveals silent myocardial dysfunction in Kawasaki disease.
Topics: Adolescent; Adrenergic beta-Agonists; Blood Pressure; Cardiomyopathies; Child; Child, Preschool; Cor | 2002 |
Myocardial ischemia in Kawasaki disease; evaluation by dipyridamole stress thallium-201 (Tl-201) myocardial imaging and exercise stress test.
Topics: Adolescent; Child; Child, Preschool; Dipyridamole; Exercise Test; Female; Humans; Infant; Male; Muco | 1992 |
[Effects of isosorbide dinitrate on coronary and systemic circulation in children: comparison with dipyridamole].
Topics: Adolescent; Blood Circulation; Child; Child, Preschool; Coronary Circulation; Coronary Vessels; Dipy | 1992 |
Assessment of left ventricular function in Kawasaki disease by dipyridamole-loading cineventriculography.
Topics: Child; Child, Preschool; Cineradiography; Dipyridamole; Female; Heart Rate; Heart Ventricles; Humans | 1992 |
[Exercise and dipyridamole-loading in evaluation of ischemic coronary lesion and coronary reserve in children with Kawasaki disease].
Topics: Adolescent; Child; Coronary Circulation; Coronary Disease; Dipyridamole; Electrocardiography; Exerci | 1991 |
[Regression of coronary artery aneurysm in a patient with Kawasaki's disease].
Topics: Aspirin; Coronary Aneurysm; Dipyridamole; Echocardiography; Female; Humans; Infant; Mucocutaneous Ly | 1991 |
[Usefulness and limitations of stress 201-thallium myocardial imaging in patients with Kawasaki disease].
Topics: Adolescent; Child; Child, Preschool; Coronary Angiography; Coronary Disease; Dipyridamole; Exercise | 1991 |
Clinical aspects of 100 patients with Kawasaki disease.
Topics: Aspirin; Blood Sedimentation; Child; Child, Preschool; Coronary Aneurysm; Coronary Disease; Dipyrida | 1991 |
Dipyridamole-induced ischemia in a child with jeopardized collaterals after Kawasaki syndrome.
Topics: Child, Preschool; Collateral Circulation; Coronary Aneurysm; Coronary Circulation; Coronary Disease; | 1990 |
Detection of coronary artery stenosis in children with Kawasaki disease. Usefulness of pharmacologic stress 201Tl myocardial tomography.
Topics: Adolescent; Child; Child, Preschool; Color; Constriction, Pathologic; Coronary Aneurysm; Coronary An | 1989 |
Dipyridamole-thallium-201 tomography documenting improved myocardial perfusion with therapy in Kawasaki disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; | 1988 |
Coronary angiography of Kawasaki disease with the coronary vasodilator dipyridamole: assessment of distensibility of affected coronary arterial wall.
Topics: Acute Disease; Adolescent; Blood Pressure; Child; Child, Preschool; Cineangiography; Coronary Aneury | 1988 |
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age.
Topics: Aspirin; Coronary Aneurysm; Dipyridamole; Drug Therapy, Combination; Echocardiography; Electrocardio | 1986 |